Insights into the neurodevelopmental origin of schizophrenia from postmortem studies of prefrontal cortical circuitry

International Journal of Developmental Neuroscience

Volumn 29, Issue 3, 2011, Pages 295-304

  Beneyto, Monica ^a   Lewis, David A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Development; GABA; Glutamate; Neurotransmission

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; MESSENGER RNA;

ARTICLE; AUTOPSY; BRAIN CORTEX; COGNITION; DISEASE PREDISPOSITION; GABAERGIC TRANSMISSION; GENE EXPRESSION REGULATION; GENOTYPE ENVIRONMENT INTERACTION; HIGH RISK PATIENT; HUMAN; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NONHUMAN; POSTNATAL DEVELOPMENT; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNAPTIC EFFICACY;

AUTOPSY; BIOLOGICAL MARKERS; GAMMA-AMINOBUTYRIC ACID; HUMANS; NERVE NET; PREFRONTAL CORTEX; PROTEIN SUBUNITS; RECEPTORS, GABA-A; SCHIZOPHRENIA;

EID: 78149448002     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2010.08.003     Document Type: Article

References (105)

1. Akbarian S., Huang H.S. Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res. Rev. 2006, 52:293-304.
2. Akbarian S., Huntsman M.M., Kim J.J., Tafazzoli A., Potkin S.G., Bunney W.E., Jones E.G. GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls. Cereb. Cortex 1995, 5:550-560.
3. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney W.E., Jones E.G. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry 1995, 52:258-266.
4. Alexander G.E., Goldman P.S. Functional development of the dorsolateral prefrontal cortex: an analysis utlizing reversible cryogenic depression. Brain Res. 1978, 143:233-249.
5. Anderson S.A., Classey J.D., Conde F., Lund J.S., Lewis D.A. Synchronous development of pyramidal neuron dendritic spines and parvalbumin-immunoreactive chandelier neuron axon terminals in layer III of monkey prefrontal cortex. Neuroscience 1995, 67:7-22.
6. Asada H., Kawamura Y., Maruyama K., Kume H., Ding R.G., Kanbara N., Kuzume H., Sanbo M., Yagi T., Obata K. Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:6496-6499.
7. Barbas H. Architecture and cortical connections of the prefrontal cortex in the rhesus monkey. Adv. Neurol. 1992, 57:91-115.
8. Bartos M., Vida I., Jonas P. Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat. Rev. Neurosci. 2007, 8:45-56.
9. Beneyto M, Abbott A, Hashimoto T, and Lewis DA (2010). Lamina-specific alterations in cortical GABAA receptor subunit expression in schizophrenia. Cerebral Cortex (in press).
10. Bianchi M.T., Macdonald R.L. Neurosteroids shift partial agonist activation of GABA(A) receptor channels from low- to high-efficacy gating patterns. J. Neurosci. 2003, 23:10934-10943.
11. Bird E.D., Spokes E.G., Iversen L.L. Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia. Brain 1979, 102:347-360.
12. Bodor A.L., Katona I., Nyiri G., Mackie K., Ledent C., Hajos N., Freund T.F. Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types. J. Neurosci. 2005, 25:6845-6856.
13. Bourgeois J.P., Goldman-Rakic P.S., Rakic P. Synaptogenesis in the prefrontal cortex of rhesus monkeys. Cereb. Cortex 1994, 4:78-96.
14. Callicott J.H., Mattay V.S., Verchinski B.A., Marenco S., Egan M.F., Weinberger D.R. Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. Am. J. Psychiatry 2003, 160:2209-2215.
15. Choi K.H., Zepp M.E., Higgs B.W., Weickert C.S., Webster M.J. Expression profiles of schizophrenia susceptibility genes during human prefrontal cortical development. J. Psychiatry Neurosci. 2009, 34:450-458.
16. Conde F., Lund J.S., Jacobowitz D.M., Baimbridge K.G., Lewis D.A. Local circuit neurons immunoreactive for calretinin, calbindin D-28k or parvalbumin in monkey prefrontal cortex: distribution and morphology. J. Comp. Neurol. 1994, 341:95-116.
17. Conde F., Lund J.S., Lewis D.A. The hierarchical development of monkey visual cortical regions as revealed by the maturation of parvalbumin-immunoreactive neurons. Brain Res. Dev. Brain Res. 1996, 96:261-276.
18. Crone E.A., Wendelken C., Donohue S., van Leijenhorst L., Bunge S.A. Neurocognitive development of the ability to manipulate information in working memory. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:9315-9320.
19. Cruz D.A., Eggan S.M., Lewis D.A. Postnatal development of pre- and postsynaptic GABA markers at chandelier cell connections with pyramidal neurons in monkey prefrontal cortex. J. Comp. Neurol. 2003, 465:385-400.
20. Cruz D.A., Lovallo E.M., Stockton S., Rasband M., Lewis D.A. Postnatal development of synaptic structure proteins in pyramidal neuron axon initial segments in monkey prefrontal cortex. J. Comp. Neurol. 2009, 514:353-367.
21. Cruz D.A., Weaver C.L., Lovallo E.M., Melchitzky D.S., Lewis D.A. Selective alterations in postsynaptic markers of chandelier cell inputs to cortical pyramidal neurons in subjects with schizophrenia. Neuropsychopharmacology 2009, 34:2112-2124.
22. DeFelipe J. Types of neurons, synaptic connections and chemical characteristics of cells immunoreactive for calbindin-D28K, parvalbumin and calretinin in the neocortex. J. Chem. Neuroanat. 1997, 14:1-19.
23. Deshmukh S., Onozuka K., Bender K.J., Bender V.A., Lutz B., Mackie K., Feldman D.E. Postnatal development of cannabinoid receptor type 1 expression in rodent somatosensory cortex. Neuroscience 2007, 145:279-287.
24. Diamond A., Kirkham N., Amso D. Conditions under which young children can hold two rules in mind and inhibit a prepotent response. Dev. Psychol. 2002, 38:352-362.
25. Duncan C.E., Webster M.J., Rothmond D.A., Bahn S., Elashoff M., Shannon Weickert C. Prefrontal GABA(A) receptor alpha-subunit expression in normal postnatal human development and schizophrenia. J. Psychiatr. Res. 2010, 44:673-681.
26. Eggan S.M., Hashimoto T., Lewis D.A. Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia. Arch. Gen. Psychiatry 2008, 65:772-784.
27. Eggan S.M., Lewis D.A. Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cereb. Cortex 2007, 17:175-191.
28. Eggan S.M., Mizoguchi Y., Stoyak S.R., Lewis D.A. Development of cannabinoid 1 receptor protein and messenger RNA in monkey dorsolateral prefrontal cortex. Cereb. Cortex 2010, 20:1164-1174.
29. Erickson S.L., Lewis D.A. Postnatal development of parvalbumin- and GABA transporter-immunoreactive axon terminals in monkey prefrontal cortex. J. Comp. Neurol. 2002, 448:186-202.
30. Farrant M., Nusser Z. Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat. Rev. Neurosci. 2005, 6:215-229.
31. Feinberg I. Cortical pruning and the development of schizophrenia. Schizophr. Bull. 1990, 16:567-570.
32. Fillman S.G., Duncan C.E., Webster M.J., Elashoff M., Weickert C.S. Developmental co-regulation of the [beta] and [gamma] GABAA receptor subunits with distinct [alpha] subunits in the human dorsolateral prefrontal cortex. Int. J. Neurosci. 2010, 28:513-519.
33. Freund T.F., Katona I., Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 2003, 83:1017-1066.
34. Fritschy J.M., Mohler H. GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J. Comp. Neurol. 1995, 359:154-194.
35. Gabbott P.L., Bacon S.J. Local circuit neurons in the medial prefrontal cortex (areas 24a,b,c, 25 and 32) in the monkey: II. Quantitative areal and laminar distributions. J. Comp. Neurol. 1996, 364:609-636.
36. Galarreta M., Erdelyi F., Szabo G., Hestrin S. Electrical coupling among irregular-spiking GABAergic interneurons expressing cannabinoid receptors. J. Neurosci. 2004, 24:9770-9778.
37. Goldman-Rakic P.S. Working memory dysfunction in schizophrenia. J. Neuropsychiatry Clin. Neurosci. 1994, 6:348-357.
38. Goldman-Rakic P.S. Cellular basis of working memory. Neuron 1995, 14:477-485.
39. Gonzalez-Burgos G., Krimer L.S., Povysheva N.V., Barrionuevo G., Lewis D.A. Functional properties of fast spiking interneurons and their synaptic connections with pyramidal cells in primate dorsolateral prefrontal cortex. J. Neurophysiol. 2005, 93:942-953.
40. Gonzalez-Burgos G., Kroener S., Zaitsev A.V., Povysheva N.V., Krimer L.S., Barrionuevo G., Lewis D.A. Functional maturation of excitatory synapses in layer 3 pyramidal neurons during postnatal development of the primate prefrontal cortex. Cereb. Cortex 2008, 18:626-637.
41. Gonzalez-Burgos G., Lewis D.A. GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr. Bull. 2008, 34:944-961.
42. Guidotti A., Auta J., Davis J.M., Di-Giorgi-Gerevini V., Dwivedi Y., Grayson D.R., Impagnatiello F., Pandey G., Pesold C., Sharma R., Uzunov D., Costa E., DiGiorgi Gerevini V. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen. Psychiatry 2000, 57:1061-1069.
43. Harris L.W., Lockstone H.E., Khaitovich P., Weickert C.S., Webster M.J., Bahn S. Gene expression in the prefrontal cortex during adolescence: implications for the onset of schizophrenia. BMC Med. Genom. 2009, 2:28.
44. Hashimoto T., Arion D., Unger T., Maldonado-Aviles J.G., Morris H.M., Volk D.W., Mirnics K., Lewis D.A. Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol. Psychiatry 2008, 13:147-161.
45. Hashimoto T., Bazmi H.H., Mirnics K., Wu Q., Sampson A.R., Lewis D.A. Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Am. J. Psychiatry 2008, 165:479-489.
46. Hashimoto T., Bergen S.E., Nguyen Q.L., Xu B., Monteggia L.M., Pierri J.N., Sun Z., Sampson A.R., Lewis D.A. Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J. Neurosci. 2005, 25:372-383.
47. Hashimoto T., Nguyen Q.L., Rotaru D., Keenan T., Arion D., Beneyto M., Gonzalez-Burgos G., Lewis D.A. Protracted developmental trajectories of GABAA receptor alpha1 and alpha2 subunit expression in primate prefrontal cortex. Biol. Psychiatry 2009, 65:1015-1023.
48. Hashimoto T., Volk D.W., Eggan S.M., Mirnics K., Pierri J.N., Sun Z., Sampson A.R., Lewis D.A. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J. Neurosci. 2003, 23:6315-6326.
49. Heizmann C.W. Parvalbumin, an intracellular calcium-binding protein; distribution, properties and possible roles in mammalian cells. Experientia 1984, 40:910-921.
50. Huang Z.J. Activity-dependent development of inhibitory synapses and innervation pattern: role of GABA signalling and beyond. J. Physiol. 2009, 587:1881-1888.
51. Huntsman M.M., Tran B.V., Potkin S.G., Bunney W.E., Jones E.G. Altered ratios of alternatively spliced long and short gamma2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:15066-15071.
52. Huttenlocher P.R. Synaptic density in human frontal cortex-developmental changes and effects of aging. Brain Res. 1979, 163:195-205.
53. Huttenlocher P.R., Dabholkar A.S. Regional differences in synaptogenesis in human cerebral cortex. J. Comp. Neurol. 1997, 387:167-178.
54. Huttenlocher P.R., de Courten C. The development of synapses in striate cortex of man. Hum. Neurobiol. 1987, 6:1-9.
55. Jensen O., Kaiser J., Lachaux J.P. Human gamma-frequency oscillations associated with attention and memory. Trends Neurosci. 2007, 30:317-324.
56. Ji F., Kanbara N., Obata K. GABA and histogenesis in fetal and neonatal mouse brain lacking both the isoforms of glutamic acid decarboxylase. Neurosci. Res. 1999, 33:187-194.
57. Laminar Distribution of Cortical Efferent Cells 1984, Plenum Press, New York, pp. 521-553. E. Jones (Ed.).
58. Katagiri H., Fagiolini M., Hensch T.K. Optimization of somatic inhibition at critical period onset in mouse visual cortex. Neuron 2007, 53:805-812.
59. Kawaguchi Y., Kubota Y. Correlation of physiological subgroupings of nonpyramidal cells with parvalbumin- and calbindinD28k-immunoreactive neurons in layer V of rat frontal cortex. J. Neurophysiol. 1993, 70:387-396.
60. Keshavan M.S., Anderson S., Pettegrew J.W. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J. Psychiatr. Res. 1994, 28:239-265.
61. Kisvarday Z.F., Beaulieu C., Eysel U.T. Network of GABAergic large basket cells in cat visual cortex (area 18): implication for lateral disinhibition. J. Comp. Neurol. 1993, 327:398-415.
62. Klausberger T., Roberts J.D., Somogyi P. Cell type- and input-specific differences in the number and subtypes of synaptic GABA(A) receptors in the hippocampus. J. Neurosci. 2002, 22:2513-2521.
63. Krimer L.S., Goldman-Rakic P.S. Prefrontal microcircuits: membrane properties and excitatory input of local, medium, and wide arbor interneurons. J. Neurosci. 2001, 21:3788-3796.
64. Krimer L.S., Zaitsev A.V., Czanner G., Kroner S., Gonzalez-Burgos G., Povysheva N.V., Iyengar S., Barrionuevo G., Lewis D.A. Cluster analysis-based physiological classification and morphological properties of inhibitory neurons in layers 2-3 of monkey dorsolateral prefrontal cortex. J. Neurophysiol. 2005, 94:3009-3022.
65. Levitt J.B., Lewis D.A., Yoshioka T., Lund J.S. Topography of pyramidal neuron intrinsic connections in macaque monkey prefrontal cortex (areas 9 and 46). J. Comp. Neurol. 1993, 338:360-376.
66. Lewis D.A., Cruz D.A., Melchitzky D.S., Pierri J.N. Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus. Am. J. Psychiatry 2001, 158:1411-1422.
67. Lewis D.A., Gonzalez-Burgos G. Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacology 2008, 33:141-165.
68. Lewis D.A., Hashimoto T., Volk D.W. Cortical inhibitory neurons and schizophrenia. Nat. Rev. Neurosci. 2005, 6:312-324.
69. Lewis D.A., Levitt P. Schizophrenia as a disorder of neurodevelopment. Annu. Rev. Neurosci. 2002, 25:409-432.
70. Lewis D.A., Lund J.S. Heterogeneity of chandelier neurons in monkey neocortex: corticotropin-releasing factor- and parvalbumin-immunoreactive populations. J. Comp. Neurol. 1990, 293:599-615.
71. Loup F., Picard F., Andre V.M., Kehrli P., Yonekawa Y., Wieser H.G., Fritschy J.M. Altered expression of alpha3-containing GABAA receptors in the neocortex of patients with focal epilepsy. Brain 2006, 129:3277-3289.
72. Loup F., Weinmann O., Yonekawa Y., Aguzzi A., Wieser H.G., Fritschy J.M. A highly sensitive immunofluorescence procedure for analyzing the subcellular distribution of GABAA receptor subunits in the human brain. J. Histochem. Cytochem. 1998, 46:1129-1139.
73. Luna B., Garver K.E., Urban T.A., Lazar N.A., Sweeney J.A. Maturation of cognitive processes from late childhood to adulthood. Child Dev. 2004, 75:1357-1372.
74. Lund J.S., Lewis D.A. Local circuit neurons of developing and mature macaque prefrontal cortex: Golgi and immunocytochemical characteristics. J. Comp. Neurol. 1993, 328:282-312.
75. Maldonado-Aviles J.G., Curley A.A., Hashimoto T., Morrow A.L., Ramsey A.J., O'Donnell P., Volk D.W., Lewis D.A. Altered markers of tonic inhibition in the dorsolateral prefrontal cortex of subjects with schizophrenia. Am. J. Psychiatry 2009, 166:450-459.
76. Marsicano G., Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur. J. Neurosci. 1999, 11:4213-4225.
77. Mertens S., Benke D., Mohler H. GABAA receptor populations with novel subunit combinations and drug binding profiles identified in brain by alpha 5- and delta-subunit-specific immunopurification. J. Biol. Chem. 1993, 268:5965-5973.
78. Mirnics K., Middleton F.A., Lewis D.A., Levitt P. Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci. 2001, 24:479-486.
79. Mirnics K., Middleton F.A., Marquez A., Lewis D.A., Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 2000, 28:53-67.
80. Mohler H. GABA(A) receptor diversity and pharmacology. Cell Tissue Res. 2006, 326:505-516.
81. Morozov Y.M., Freund T.F. Post-natal development of type 1 cannabinoid receptor immunoreactivity in the rat hippocampus. Eur. J. Neurosci. 2003, 18:1213-1222.
82. Nusser Z., Sieghart W., Benke D., Fritschy J.M., Somogyi P. Differential synaptic localization of two major gamma-aminobutyric acid type A receptor alpha subunits on hippocampal pyramidal cells. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:11939-11944.
83. Nyiri G., Freund T.F., Somogyi P. Input-dependent synaptic targeting of alpha(2)-subunit-containing GABA(A) receptors in synapses of hippocampal pyramidal cells of the rat. Eur. J. Neurosci. 2001, 13:428-442.
84. Oeth K.M., Lewis D.A. Cholecystokinin innervation of monkey prefrontal cortex: an immunohistochemical study. J. Comp. Neurol. 1990, 301:123-137.
85. Oeth K.M., Lewis D.A. Postnatal development of the cholecystokinin innervation of monkey prefrontal cortex. J. Comp. Neurol. 1993, 336:400-418.
86. Ohnuma T., Augood S.J., Arai H., McKenna P.J., Emson P.C. Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: focus on GABA content, GABA(A) receptor alpha-1 subunit messenger RNA and human GABA transporter-1 (HGAT-1) messenger RNA expression. Neuroscience 1999, 93:441-448.
87. Perlstein W.M., Carter C.S., Noll D.C., Cohen J.D. Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. Am. J. Psychiatry 2001, 158:1105-1113.
88. Pierri J.N., Chaudry A.S., Woo T.U., Lewis D.A. Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Am. J. Psychiatry 1999, 156:1709-1719.
89. Rakic P., Bourgeois J.P., Eckenhoff M.F., Zecevic N., Goldman-Rakic P.S. Concurrent overproduction of synapses in diverse regions of the primate cerebral cortex. Science 1986, 232:232-235.
90. Rao S.G., Williams G.V., Goldman-Rakic P.S. Destruction and creation of spatial tuning by disinhibition: GABA(A) blockade of prefrontal cortical neurons engaged by working memory. J. Neurosci. 2000, 20:485-494.
91. Sawaguchi T., Matsumura M., Kubota K. Delayed response deficits produced by local injection of bicuculline into the dorsolateral prefrontal cortex in Japanese macaque monkeys. Exp. Brain Res. 1989, 75:457-469.
92. Saxena N.C., Macdonald R.L. Assembly of GABAA receptor subunits: role of the delta subunit. J. Neurosci. 1994, 14:7077-7086.
93. Straub R.E., Lipska B.K., Egan M.F., Goldberg T.E., Callicott J.H., Mayhew M.B., Vakkalanka R.K., Kolachana B.S., Kleinman J.E., Weinberger D.R. Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Mol. Psychiatry 2007, 12:854-869.
94. Thompson M., Weickert C.S., Wyatt E., Webster M.J. Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders. J. Psychiatr. Res. 2009, 43:970-977.
95. Uhlhaas P.J., Linden D.E., Singer W., Haenschel C., Lindner M., Maurer K., Rodriguez E. Dysfunctional long-range coordination of neural activity during Gestalt perception in schizophrenia. J. Neurosci. 2006, 26:8168-8175.
96. Vawter M.P., Crook J.M., Hyde T.M., Kleinman J.E., Weinberger D.R., Becker K.G., Freed W.J. Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr. Res. 2002, 58:11-20.
97. Volk D., Austin M., Pierri J., Sampson A., Lewis D. GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons. Am. J. Psychiatry 2001, 158:256-265.
98. Volk D.W., Austin M.C., Pierri J.N., Sampson A.R., Lewis D.A. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch. Gen. Psychiatry 2000, 57:237-245.
99. Volk D.W., Pierri J.N., Fritschy J.M., Auh S., Sampson A.R., Lewis D.A. Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb. Cortex 2002, 12:1063-1070.
100. Weickert C.S., Webster M.J., Gondipalli P., Rothmond D., Fatula R.J., Herman M.M., Kleinman J.E., Akil M. Postnatal alterations in dopaminergic markers in the human prefrontal cortex. Neuroscience 2007, 144:1109-1119.
101. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 1987, 44:660-669.
102. Weinberger D.R., Berman K.F., Zec R.F. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch. Gen. Psychiatry 1986, 43:114-124.
103. Woo T.U., Walsh J.P., Benes F.M. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-d-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch. Gen. Psychiatry 2004, 61:649-657.
104. Woo T.U., Whitehead R.E., Melchitzky D.S., Lewis D.A. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:5341-5346.
105. Zaitsev A.V., Gonzalez-Burgos G., Povysheva N.V., Kroner S., Lewis D.A., Krimer L.S. Localization of calcium-binding proteins in physiologically and morphologically characterized interneurons of monkey dorsolateral prefrontal cortex. Cereb. Cortex 2005, 15:1178-1186.